$GRWG

GrowGeneration Corp. 1Q 2026: Revenue $38.39M, EPS ($0.08) — 10-Q Summary

GrowGeneration Corp. reported its first-quarter 2026 results, showing a 7.5% increase in revenue to $38.39M and a reduced net loss of ($4.92M), leading to an improved diluted loss per share of ($0.08). The growth was driven by demand for durable products and Storage Solutions, with proprietary brands also contributing significantly. The company continued its store rationalization efforts, closing four additional locations while maintaining solid liquidity with $41.1M in cash and marketable securities.

Original reporting
Published May 13, 2026, 4:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 13, 2026, 4:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$GRWG
Neutral
medium confidence
Mentioned
$GRWG
alphai data visualization · based on TradingView
Decision brief

The 30-second read

$GRWGNeutralLow
01

Why it matters

The quarterly results indicate operational adjustments are beginning to yield benefits, but the company's profitability remains fragile.

02

Market read

The company's financial performance has marginally improved, which may influence short-term trading decisions, but broader sector and market factors are more significant.

03

What to watch

Broader industry headwinds, regulatory changes, or supply chain issues could offset the positive financial indicators.

Timing: short-term (next 1-2 weeks)

Background

GrowGeneration Corp. operates in the specialty retail sector, focusing on hydroponic and indoor gardening supplies, with recent efforts to streamline operations.

Company-level read

Ticker impact

$GRWGNeutralMedium confidence
Context

The news pertains to GrowGeneration Corp.'s quarterly financial results, which is directly relevant to its stock performance.

Expected impact

Potential short-term stabilization or slight upward movement due to improved financials, but overall limited impact on stock price.

Evidence & confidence

While the financial results show positive signs, the modest growth and ongoing store rationalization suggest limited immediate impact. Market reaction may be subdued, and broader industry trends should be considered.

Market effects

Potential slight positive bias towards retail and specialty sectors involved in durable goods and storage solutions.

Limited; primarily affects the company's regional markets with no significant macroeconomic implications.

negligible; the news is specific to a regional company with limited global influence.

Counterpoint

The improved quarterly results may be temporary; ongoing store closures and net losses suggest underlying challenges that could resurface.

Key entities

  • GrowGeneration Corp.

    A retailer specializing in hydroponic gardening supplies.

Related articles

$GRWGMedAI 8/10

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration Corp. (GRWG) reported Q2 2026 results: a 3-cent per-share loss, narrower than the Zacks Consensus estimate of a 4-cent loss and versus an 8-cent loss a year earlier. Sales rose 5.5% to $43.2M. Adjusted EBITDA was $0.3M. The company raised full-year adjusted EBITDA guidance to $2–$3M and reaffirmed sales guidance of $162–$168M.

$GRWGMedAI 8/10

GrowGeneration Corp. Q2 2026 Earnings Call Summary

GrowGeneration Corp. reported a third straight quarter of YoY revenue growth, citing a shift to a commercial B2B platform and proprietary brands. Proprietary brand penetration reached 40% ahead of schedule. The company cut store and operating expenses 22% YoY and raised full-year 2026 adjusted EBITDA guidance to $2M-$3M, aided by expected Q3 IEPA tariff refunds. It repurchased 700,000 shares at $1.38.

$GRWGMedAI 8/10

GrowGeneration (GRWG) Q2 2026 Earnings Call Transcript

GrowGeneration (GRWG) reported Q2 2026 revenue of $43.2 million, up 5.5% year over year, with adjusted EBITDA of $0.3 million versus a $1.3 million loss a year earlier. Net loss narrowed to $2.0 million. Gross margin rose to 28.5%. Full-year 2026 guidance: revenue $162-$168 million and adjusted EBITDA $2-$3 million. Cash was $41 million with no debt.

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.